European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading
Biotech Stocks: Which Drugmakers Are Worth a Buy?
10 Health Care Stocks With Whale Alerts In Today's Session
Piper Lists Eight Defensive Biotechs to Face Market Volatility
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Express News | Barclays Upgrades Argenx to Overweight
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), IGC Pharma (IGC) and Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
Express News | Argenx SE : Baird Raises Target Price to $515 From $490
The Analyst Verdict: Argenx In The Eyes Of 27 Experts
Jefferies Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $598
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Baird Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $515
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Truist Financial Keeps Their Buy Rating on Argenx Se (ARGX)
Express News | Baird Maintains Outperform on Argenx, Raises Price Target to $515
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Boston Scientific (BSX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $533 to $585
Argenx Is Maintained at Outperform by Oppenheimer
Argenx Price Target Raised to $547.00/Share From $543.00 by Wells Fargo
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $497 to $598